Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 169
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

    This survey research study aims to explore the amount of confidence emergency physicians have with treating...

    Can a crocodile cure your ills? Testing the Crocodylus Apothecary Hypothesis

    Why did alchemists hang crocodiles from the ceilings of their shops? Why did ancient Egyptians worship crocodiles...

    Can albumin from egg whites be used to treat Clostridium difficile infections?

    Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

    Backer Badge Funded